Edition:
United Kingdom

Merck KGaA (MRCG.DE)

MRCG.DE on Xetra

94.90EUR
23 Aug 2019
Change (% chg)

-- (--)
Prev Close
€94.90
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
482,231
52-wk High
€102.90
52-wk Low
€85.06

About

Merck KGaA is a Germany-based science and technology company. The Company operates in three business segments: Healthcare, Life Sciences and Performance Materials. The Healthcare business, which operates in the United States and Canada as EMD Serono, focuses on such therapeutic areas as allergies, fertility, oncology and... (more)

Overall

Beta: 1.01
Market Cap(Mil.): €12,352.97
Shares Outstanding(Mil.): 129.24
Dividend: 1.20
Yield (%): 1.26

Financials

  MRCG.DE Industry Sector
P/E (TTM): 24.91 29.89 32.67
EPS (TTM): 3.84 -- --
ROI: 5.93 14.89 14.48
ROE: 12.78 16.01 15.78

Merck KGaA's profit bolstered by lab supplies, drug milestone payments

FRANKFURT Germany's Merck KGaA posted a gain in quarterly earnings that was slightly higher than market expectations thanks to strong sales growth at its lab supplies unit and milestone payments from drug development partners.

08 Aug 2019

Merck KGaA's profit bolstered by lab supplies, drug milestone payments

FRANKFURT Germany's Merck KGaA posted a gain in quarterly earnings that was slightly higher than market expectations thanks to strong sales growth at its lab supplies unit and milestone payments from drug development partners.

08 Aug 2019

UPDATE 1-Merck KGaA's profit bolstered by lab supplies, drug milestone payments

* Life Science unit boosted by demand for lab supplies and gear

08 Aug 2019

Merck KGaA's Q2 profit bolstered by drug milestone payments

FRANKFURT, Aug 8 Germany's Merck KGaA posted a gain in quarterly earnings that was slightly higher than market expectations, driven by drug development milestone payments from partners Pfizer and GlaxoSmithKline .

08 Aug 2019

Roche brags about faster Ocrevus sales after rival MS drug launches

ZURICH Roche took a swipe at rival drugmakers on Thursday saying their attempts to muscle in to the multiple sclerosis market had only boosted sales of its own product.

25 Jul 2019

CORRECTED-The $280,000 lab-grown burger could be a more palatable $10 in two years

* Growing demand for meat alternatives drives research and funding

10 Jul 2019

Merck KGaA sees currencies supporting 2019 outlook

FRANKFURT Germany's Merck KGaA, which is taking over U.S. electronic chemicals maker Versum Materials, said it expected a slight tailwind from foreign exchange effects supporting earnings growth this year.

14 May 2019

Merck KGaA sees currencies supporting 2019 outlook

FRANKFURT, May 14 Germany's Merck KGaA , which is taking over U.S. electronic chemicals maker Versum Materials, said it expected a slight tailwind from foreign exchange effects supporting earnings growth this year.

14 May 2019

Merck KGaA clinches $6.5 billion Versum takeover in bet on electrochemicals

FRANKFURT Germany's Merck KGaA sealed a $6.5 billion (4.9 billion pounds) takeover deal with Versum Materials after overturning a deal it had agreed with rival bidder Entegris.

12 Apr 2019

Merck KGaA clinches $6.5 billion Versum takeover in bet on electrochemicals

FRANKFURT Germany's Merck KGaA sealed a $6.5 billion takeover deal with Versum Materials after overturning a deal it had agreed with rival bidder Entegris.

12 Apr 2019
Reuters.com is improving our Quote page. Click here to take a look and let us know what you think.

Earnings vs. Estimates